Literature DB >> 15817704

Fas-mediated death and sensory adaptation limit the pathogenic potential of autoreactive T cells after strong antigenic stimulation.

Kelli R Ryan1, David McCue, Stephen M Anderton.   

Abstract

The ability of autoreactive T cells to induce autoimmune pathology is dependent on their ability to respond to the level of autoantigen presented in the target organ. Emerging evidence suggests that at the population level, T cell sensitivity for self can be reduced by deletion of those cells bearing high-affinity T cell receptors (TCRs) or by sensory adaptation of individual cells. Here, we have investigated the mechanisms that prevent the induction of experimental autoimmune encephalomyelitis (EAE) when myelin basic protein (MBP)-reactive T cells are exposed to a strong, antigenic stimulus. Stimulation of MBP-reactive TCR transgenic T cells with a superagonist peptide led to extensive activation-induced cell death (AICD) through Fas signaling. Using T cells lacking Fas, we found that disruption of this deletional mechanism only partially increased EAE in response to superagonist, failing to restore susceptibility to the level found in response to the wild-type MBP peptide. A significant fraction of the MBP-reactive T cells was able to avoid AICD in response to superagonist, but these cells had a reduced sensitivity for an antigen that correlated with elevated levels of CD5. Therefore, when TCR affinity is fixed, autoreactive T cell sensitivity can be shifted to below a threshold for harm by a combination of AICD and sensory adaptation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817704     DOI: 10.1189/jlb.0205059

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

1.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 2.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

Review 3.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

4.  A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.

Authors:  Maksim Mamonkin; Rayne H Rouce; Haruko Tashiro; Malcolm K Brenner
Journal:  Blood       Date:  2015-06-08       Impact factor: 22.113

5.  CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system.

Authors:  Robert C Axtell; Liang Xu; Scott R Barnum; Chander Raman
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

6.  T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens.

Authors:  Judith N Mandl; João P Monteiro; Nienke Vrisekoop; Ronald N Germain
Journal:  Immunity       Date:  2013-01-03       Impact factor: 31.745

7.  Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.

Authors:  Holger Winkels; Erik Ehinger; Melanie Vassallo; Konrad Buscher; Huy Q Dinh; Kouji Kobiyama; Anouk A J Hamers; Clément Cochain; Ehsan Vafadarnejad; Antoine-Emmanuel Saliba; Alma Zernecke; Akula Bala Pramod; Amlan K Ghosh; Nathaly Anto Michel; Natalie Hoppe; Ingo Hilgendorf; Andreas Zirlik; Catherine C Hedrick; Klaus Ley; Dennis Wolf
Journal:  Circ Res       Date:  2018-03-15       Impact factor: 17.367

8.  CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.

Authors:  Christine M Sestero; Donald J McGuire; Patrizia De Sarno; Emily C Brantley; Gloria Soldevila; Robert C Axtell; Chander Raman
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

9.  Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease.

Authors:  Maureen A McGargill; Carmen Choy; Ben G Wen; Stephen M Hedrick
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204.

Authors:  Rita G Domingues; Inês Lago-Baldaia; Isabel Pereira-Castro; Joseph M Fachini; Liliana Oliveira; Danica Drpic; Nair Lopes; Telmo Henriques; Joel R Neilson; Alexandre M Carmo; Alexandra Moreira
Journal:  Eur J Immunol       Date:  2016-04-15       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.